Contents
Contributors
Search

TABLE OF CONTENTS

  • 14.1. INTRODUCTION
  • 14.2. SYNTHETIC GLUCOCORTICOIDS (SGCs)
  • 14.3. SYSTEMIC GLUCOCORTICOID ADMINISTRATION
  • 14.3.1. Therapeutic Indications
  • 14.3.2. Adverse Effects (AEs)
  • 14.4. COMPARTMENTAL GLUCOCORTICOID ADMINISTRATION
  • 14.4.1. Topical Glucocorticoids
  • 14.4.2. Opthalmic Glucocorticoids
  • 14.4.3. Inhaled Glucocorticoids
  • 14.4.4. Nasal Glucocorticoids
  • 14.4.5. Intraarticular Glucocorticoids
  • 14.5. MONITORING OF PATIENTS ON GLUCOCORTICOID TREATMENT
  • 14.6. CONCOMITANT USE OF GLUCOCORTICOIDS WITH OTHER DRUGS
  • 14.7. PREDICTING GLUCOCORTICOID-INDUCED HPA AXIS SUPPRESSION
  • 14.8. WEANING PATIENTS FROM GLUCOCORTICOID THERAPY
  • 14.9. ACUTE ADRENAL CRISIS
  • 14.10. GLUCOCORTICOID WITHDRAWAL SYNDROME (GWS)
  • 14.11. BIOCHEMICAL DIAGNOSIS OF ADRENAL INSUFFICIENCY
  • 14.12. FUTURE PERSPECTIVES ABOUT GLUCOCORTICOID THERAPY
  • 14.13. SUMMARY